| First Author | Hayes BJ | Year | 2014 |
| Journal | PLoS One | Volume | 9 |
| Issue | 3 | Pages | e92925 |
| PubMed ID | 24667490 | Mgi Jnum | J:214150 |
| Mgi Id | MGI:5588502 | Doi | 10.1371/journal.pone.0092925 |
| Citation | Hayes BJ, et al. (2014) Activation of platelet-derived growth factor receptor alpha contributes to liver fibrosis. PLoS One 9(3):e92925 |
| abstractText | Chronic liver injury leads to fibrosis, cirrhosis, and loss of liver function. Liver cirrhosis is the 12th leading cause of death in the United States, and it is the primary risk factor for developing liver cancer. Fibrosis and cirrhosis result from activation of hepatic stellate cells (HSCs), which are the primary collagen producing cell type in the liver. Here, we show that platelet-derived growth factor receptor alpha (PDGFRalpha) is expressed by human HSCs, and PDGFRalpha expression is elevated in human liver disease. Using a green fluorescent protein (GFP) reporter mouse strain, we evaluated the role of PDGFRalpha in liver disease in mice and found that mouse HSCs express PDGFRalpha and expression is upregulated during carbon tetrachloride (CCl4) induced liver injury and fibrosis injection. This fibrotic response is reduced in Pdgfralpha heterozygous mice, consistent with the hypothesis that liver fibrosis requires upregulation and activation of PDGFRalpha. These results indicate that Pdgfralpha expression is important in the fibrotic response to liver injury in humans and mice, and suggest that blocking PDGFRalpha-specific signaling pathways in HSCs may provide therapeutic benefit for patients with chronic liver disease. |
